2nd Messenger Enzyme Immunoassays for Drug Discovery

GE Healthcare is a leading supplier of assays for a wide range of research and screening applications. These include cell signaling, tissue remodeling, metabolism and toxicology, and the study of cancer, cardiovascular and inflammatory disease states.

 The Amersham Biotrak™ range of assay kits includes non-radiometric EIA solutions to address all research, screening and lead optimization requirements of second messenger GPCR campaigns. Novel lysis reagents developed to facilitate simple and rapid extraction of cellular molecules such as cAMP and cGMP, allow elimination of  lengthy sample extraction procedures and the need to remove extraction reagents prior to measurement, as well as making the assay kits amenable to large numbers of samples.